Redhill Biopharma Ltd. - American Depositary Shares (NQ:RDHL)

0.5335 -0.0055 (-1.02%)

Delayed Quote Updated: 3:50 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Redhill Biopharma Ltd. - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Did RedHill Biopharma Shares Jump 12% Monday? ↗

October 04, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) has reported new data from the opaganib global Phase 2/3 study in hospitalized COVID-19 patients with severe pneumonia....

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 04, 2021

Gainers Longeveron (NASDAQ:LGVN) shares ...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 04, 2021

Gainers Progenity (NASDAQ:PROG) stock moved upwards by 18.43% to $2.12 during Monday's regular session. Trading volume for this security as of 12:30 EST is 91.5...

Via Benzinga

30 Stocks Moving In Monday's Mid-Day Session ↗

October 04, 2021

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all...

Via Benzinga

Cantor Sees 'Compelling Investment Opportunity' In This Biopharma ↗

August 31, 2021

Cantor Fitzgerald has

Via Benzinga

RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients

October 04, 2021

62% statistically significant reduction in mortality shown for moderately severe COVID-19 patients group treated with opaganib vs. the placebo-controlled arm (7 deaths in the 117-patient opaganib arm...

From RedHill Biopharma Ltd

Via AccessWire

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

RedHill Settles Movantik Patent Litigation With Aurobindo ↗

September 23, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced a settlement and license agreement with Aurobindo Pharma USA Inc resolving their patent litigation in...

Via Benzinga

Topics Intellectual Property

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb ↗

September 14, 2021

Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 14, 2021

Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5...

Via Benzinga

Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide ↗

September 14, 2021

Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has...

Via Benzinga

Topics Stocks

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

Why RedHill Biopharma Stock Is Getting Crushed Today ↗

September 14, 2021

A clinical failure is sending shareholders to the exits this morning.

Via The Motley Fool

Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August ↗

September 14, 2021

Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S....

Via Benzinga

Topics Stocks

What's Happening With RedHill Biopharma's Stock On Tuesday? ↗

September 14, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) announced preliminary top-line data from Phase 2/3 study evaluating opaganib in hospitalized patients with severe COVID-19...

Via Benzinga

RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa ↗

September 13, 2021

Regulatory authorities in South Africa have signed off RedHill Biopharma Ltd's (NASDAQ: RDHL) Phase 2/3 study evaluating RHB-107 (upamostat) for non-...

Via Benzinga

RHB-107 P2/3 COVID-19 Study South Africa Approval

September 13, 2021

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval The South African Health Products Regulatory...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Unveils New Movantik Data For Opioid-Induced Constipation ↗

September 07, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced new Movantik (naloxegol) Phase 3 study data analyses. The three analyses included pooled data from two Phase 3...

Via Benzinga

RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

September 07, 2021

COVID-19 and long COVID patients are at increased risk of developing kidney damage - Opaganib significantly decreased kidney fibrosis in a preclinical in vivo model - Renal fibrosis is a progressive...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma Ltd Announces New Movantik Analyses at PAINWeek

September 07, 2021

RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill to Present at HCW & Cantor Conferences

September 02, 2021

RedHill Biopharma to Present at H.C. Wainwright Annual Global Investment and Cantor Global Healthcare Conferences TEL AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / September 2, 2021 / RedHill Biopharma...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 01, 2021

Gainers INmune Bio (NASDAQ:INMB) shares ...

Via Benzinga

55 Biggest Movers From Yesterday ↗

September 01, 2021

Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it...

Via Benzinga

Why RedHill Biopharma Stock Jumped on Tuesday ↗

August 31, 2021

An analyst on Wall Street thinks the company's commercial and development pipeline has been underestimated.

Via The Motley Fool

33 Stocks Moving In Tuesday's Mid-Day Session ↗

August 31, 2021

Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021 ↗

August 31, 2021

Upgrades For GoodRx Holdings Inc (NASDAQ:GDRX),...

Via Benzinga

Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates ↗

August 31, 2021

Following the market opening Tuesday, the Dow traded down 0.04% to 35,387.11 while the NASDAQ fell 0.30% to 15,219.57. The S&P also fell, dropping 0.12% to 4,523.41. The U.S....

Via Benzinga

Topics Stocks

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.